Merus Labs International Inc (MSLI.OQ)

MSLI.OQ on NASDAQ Stock Exchange Capital Market

18 Dec 2014
Price Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for MSLI.OQ


Merus Labs International Inc. (Merus), formerly Envoy Capital Group Inc., is a specialty pharmaceutical company. The Company is engaged in the acquisition and licensing of branded prescription pharmaceutical products. It has products in the area of urology/women's health, anti-infective, and wound care. Its products include... (more)


Beta: 1.13
Market Cap (Mil.): $111.59
Shares Outstanding (Mil.): 81.23
Dividend: --
Yield (%): --


  MSLI.OQ Industry Sector
P/E (TTM): -- 36.60 37.24
EPS (TTM): -0.05 -- --
ROI: -2.50 18.95 18.21
ROE: -3.21 19.73 19.11
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: MacroRisk Analytics/EconomicInvestor
Provider: Pechala's Reports
Provider: Pechala's Reports
Provider: Reuters Investment Profile

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks